Corrigendum to “Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial” [Diabetes Res. Clin. Pract. 196 (2023) 110238]
Titel:
Corrigendum to “Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial” [Diabetes Res. Clin. Pract. 196 (2023) 110238]
Auteur:
Ruiz-de-Adana, María-Soledad Domínguez, Marta-Elena Morillas, Virginia Colomo, Natalia Vallejo-Mora, Rosario Guerrero, Mercedes García-Escobar, Eva Carreira, Mónica Romero-Zerbo, Yanina Linares, Francisca González-Mariscal, Isabel Bermúdez-Silva, Francisco-Javier Olveira, Gabriel Rojo-Martínez, Gemma